Invesco Ltd. - 89BIO INC ownership

89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 152 filers reported holding 89BIO INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of 89BIO INC
ValueSharesWeighting
Q3 2023$1,460,068
-89.7%
94,564
-87.4%
0.00%
-100.0%
Q2 2023$14,197,663
+1767.6%
749,217
+1401.0%
0.00%
Q1 2023$760,221
+6.2%
49,916
-11.2%
0.00%
Q4 2022$715,770
+11.3%
56,227
-49.4%
0.00%
Q3 2022$643,000
+62.0%
111,068
-10.0%
0.00%
Q2 2022$397,000
-49.7%
123,356
+270.4%
0.00%
Q1 2021$789,000
+4.0%
33,299
+7.0%
0.00%
Q4 2020$759,00031,1240.00%
Other shareholders
89BIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
Orchard Capital Management, LLC 551,879$7,025,4202.36%
RA Capital Management 8,955,410$114,002,3692.31%
Cormorant Asset Management, LP 2,550,000$32,4622.17%
Deep Track Capital, LP 3,850,000$49,010,5002.06%
COMMODORE CAPITAL LP 758,244$9,6521.46%
Ikarian Capital, LLC 454,000$5,779,4191.39%
DAFNA Capital Management LLC 324,173$4,126,7221.16%
Parkman Healthcare Partners LLC 332,880$4,237,5621.13%
Boxer Capital, LLC 1,400,000$17,822,0000.94%
Orbimed Advisors 3,658,869$46,577,4020.89%
View complete list of 89BIO INC shareholders